244 related articles for article (PubMed ID: 1546548)
1. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder.
Mueser KT; Yarnold PR; Bellack AS
Acta Psychiatr Scand; 1992 Jan; 85(1):48-55. PubMed ID: 1546548
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
Verdoux H; Mury M; Besançon G; Bourgeois M
Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
[TBL] [Abstract][Full Text] [Related]
3. State psychiatric hospital patients with past arrests for violent crimes.
Grossman LS; Haywood TW; Cavanaugh JL; Davis JM; Lewis DA
Psychiatr Serv; 1995 Aug; 46(8):790-5. PubMed ID: 7583479
[TBL] [Abstract][Full Text] [Related]
4. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.
Haywood TW; Kravitz HM; Grossman LS; Cavanaugh JL; Davis JM; Lewis DA
Am J Psychiatry; 1995 Jun; 152(6):856-61. PubMed ID: 7755114
[TBL] [Abstract][Full Text] [Related]
5. Substance abuse in an inpatient psychiatric sample.
Brady K; Casto S; Lydiard RB; Malcolm R; Arana G
Am J Drug Alcohol Abuse; 1991; 17(4):389-97. PubMed ID: 1746501
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
Mueser KT; Yarnold PR; Levinson DF; Singh H; Bellack AS; Kee K; Morrison RL; Yadalam KG
Schizophr Bull; 1990; 16(1):31-56. PubMed ID: 2333480
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
8. Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
Strakowski SM; Tohen M; Flaum M; Amador X
Schizophr Res; 1994 Dec; 14(1):73-81. PubMed ID: 7893624
[TBL] [Abstract][Full Text] [Related]
9. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.
Rabinowitz J; Bromet EJ; Lavelle J; Carlson G; Kovasznay B; Schwartz JE
Psychol Med; 1998 Nov; 28(6):1411-9. PubMed ID: 9854282
[TBL] [Abstract][Full Text] [Related]
11. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of cycloid psychosis.
Lindvall M; Hagnell O; Ohman R
Psychopathology; 1990; 23(4-6):228-32. PubMed ID: 2084774
[TBL] [Abstract][Full Text] [Related]
13. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness.
Warner R; Taylor D; Wright J; Sloat A; Springett G; Arnold S; Weinberg H
Am J Orthopsychiatry; 1994 Jan; 64(1):30-9. PubMed ID: 8147425
[TBL] [Abstract][Full Text] [Related]
14. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
Carey KB; Cocco KM; Simons JS
Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
[TBL] [Abstract][Full Text] [Related]
15. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences.
Benabarre A; Vieta E; Colom F; Martínez-Arán A; Reinares M; Gastó C
Eur Psychiatry; 2001 Apr; 16(3):167-72. PubMed ID: 11353595
[TBL] [Abstract][Full Text] [Related]
16. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide.
Harkavy-Friedman JM; Restifo K; Malaspina D; Kaufmann CA; Amador XF; Yale SA; Gorman JM
Am J Psychiatry; 1999 Aug; 156(8):1276-8. PubMed ID: 10450275
[TBL] [Abstract][Full Text] [Related]
17. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
Peralta V; Cuesta MJ
J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in affective, schizoaffective, and schizophrenic disorders. A review.
Bardenstein KK; McGlashan TH
Schizophr Res; 1990; 3(3):159-72. PubMed ID: 2278981
[TBL] [Abstract][Full Text] [Related]
19. Illicit-drug injection among psychiatric patients without a primary substance use disorder.
Horwath E; Cournos F; McKinnon K; Guido JR; Herman R
Psychiatr Serv; 1996 Feb; 47(2):181-5. PubMed ID: 8825256
[TBL] [Abstract][Full Text] [Related]
20. The problem of detecting changes in the incidence of schizophrenia.
Kendell RE; Malcolm DE; Adams W
Br J Psychiatry; 1993 Feb; 162():212-8. PubMed ID: 8435692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
